Devdatt Kurdikar

Devdatt (Dev) Kurdikar currently serves as the President and CEO of embecta, where they are dedicated to improving access to diabetes care globally. With a notable background in leadership roles across various medical technology firms, Dev has demonstrated a strong strategic mindset and a commitment to building high-performing teams. They previously held positions at companies such as Boston Scientific and Cardiac Science, contributing to business transformations and successful market exits. Dev is also involved in multiple boards, including Zimmer Biomet and AdvaMed, consistently working to advance health technologies.